Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 17 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Coherus Oncology, Inc. | 20,000 | reported | 01 Feb 2018 | tx 30+2,706,572−3,206,572 |
| Medpace Holdings, Inc. | 10,000 | reported | 24 Apr 2026 | tx 311+4,009,684−9,381,372 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Apr 2026 | GRANT_AWARD | Medpace Holdings, Inc. | 20,000 | 0.00 USD | deriv |
| 24 Apr 2026 | GRANT_AWARD | Medpace Holdings, Inc. | 10,000 | 0.00 USD | deriv |
| 03 Dec 2025 | SALE | Medpace Holdings, Inc. | 668 | 590.69 USD | |
| 01 Dec 2025 | SALE | Medpace Holdings, Inc. | 23,178 | 593.25 USD | |
| 02 Dec 2025 | SALE | Medpace Holdings, Inc. | 5,698 | 590.47 USD | |
| 26 Nov 2025 | SALE | Medpace Holdings, Inc. | 41,331 | 606.88 USD | |
| 28 Nov 2025 | SALE | Medpace Holdings, Inc. | 15,151 | 593.46 USD | |
| 24 Nov 2025 | SALE | Medpace Holdings, Inc. | 59,025 | 607.78 USD | |
| 25 Nov 2025 | SALE | Medpace Holdings, Inc. | 42,392 | 615.52 USD | |
| 20 Nov 2025 | SALE | Medpace Holdings, Inc. | 6,830 | 598.49 USD | |
| 21 Nov 2025 | SALE | Medpace Holdings, Inc. | 21,858 | 592.18 USD | |
| 19 Nov 2025 | SALE | Medpace Holdings, Inc. | 23,862 | 592.07 USD | |
| 18 Nov 2025 | SALE | Medpace Holdings, Inc. | 7,191 | 590.84 USD | |
| 17 Nov 2025 | SALE | Medpace Holdings, Inc. | 6,047 | 591.00 USD | |
| 14 Nov 2025 | SALE | Medpace Holdings, Inc. | 14,747 | 595.26 USD | |
| 12 Nov 2025 | SALE | Medpace Holdings, Inc. | 5,312 | 603.23 USD | |
| 13 Nov 2025 | SALE | Medpace Holdings, Inc. | 5,128 | 601.37 USD | |
| 29 Aug 2025 | SALE | Medpace Holdings, Inc. | 36,196 | 475.90 USD | |
| 02 Sept 2025 | SALE | Medpace Holdings, Inc. | 1,197 | 475.11 USD | |
| 27 Aug 2025 | SALE | Medpace Holdings, Inc. | 620 | 475.00 USD | |
| 28 Jul 2025 | SALE | Medpace Holdings, Inc. | 48,487 | 451.69 USD | |
| 07 Mar 2025 | EXERCISE | Medpace Holdings, Inc. | 234,259 | 56.61 USD | |
| 07 Mar 2025 | EXERCISE | Medpace Holdings, Inc. | 84,770 | 107.93 USD | |
| 07 Mar 2025 | EXERCISE | Medpace Holdings, Inc. | 37,417 | 54.74 USD | |
| 06 Mar 2025 | GRANT_AWARD | Medpace Holdings, Inc. | 73,443 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 14 Jul 2022.